Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: GSK 10.595, Sanofi 13.284.
GSK vs Sanofi: Revenue Comparison
GSK (GSK) and Sanofi (SNY) are peers in Vaccines. GSK reported revenue of $10.6B as of Q2 2026, compared with $13.3B for Sanofi. Sanofi leads on revenue.
GSK's gross margin is 73.0% versus 75.5% for Sanofi. GSK's net margin is 5.2% versus 2.8% for Sanofi.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, GSK, Sanofi.| Metric | GSK | Sanofi |
|---|---|---|
| Market Cap | - | - |
| Revenue | $10.60B | $13.28B |
| Cost of Revenue | $2.85B | $3.26B |
| Gross Profit | $7.74B | $10.03B |
| Operating Income | $606.00M | $2.58B |
| Net Income | $548.00M | $370.00M |
| R&D Expense | $4.37B | $2.41B |
| Earnings Per Share | $0.28 | $0.15 |
| Gross Margin | 73.0% | 75.5% |
| Operating Margin | 5.7% | 19.4% |
| Net Profit Margin | 5.2% | 2.8% |
| Free Cash Flow | $2.78B | $4.22B |
| Cumulative Free Cash Flow | $157.21B | $51.81B |
| Operating Cash Flow | $3.19B | $5.85B |
| Cash & Equivalents | $3.89B | $6.86B |